Augmont Enterprises Limited reports on IPO proceeds utilization for Q3 2026

Augmont Enterprises Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, detailing the utilization of funds raised through its Initial Public Offering (IPO). The report, issued by CARE Ratings Limited, confirms that the company has utilized ₹465.23 crore towards its working capital objectives, slightly exceeding the projected ₹465 crore. No material deviations were observed in the utilization of proceeds.

Augmont Enterprises Limited Submits Monitoring Agency Report

Augmont Enterprises Limited has formally submitted its Monitoring Agency Report for the quarter concluding on September 30, 2026. This report, a regulatory requirement for companies that have raised funds through public issues, details the utilization of the IPO proceeds. The submission was made to both the BSE Limited and the National Stock Exchange of India Limited on November 6, 2026.

Utilization of IPO Proceeds

According to the report compiled by CARE Ratings Limited, Augmont Enterprises has utilized ₹465.23 crore of the IPO funds. This amount was allocated towards working capital purposes, which included the procurement, maintenance, and scaling up of inventory, as well as funding advance margin requirements. This figure is marginally higher than the ₹465 crore originally earmarked in the offer document for this objective.

The company has also utilized ₹107.76 crore for general corporate purposes, aligning with the disclosures in the offer document. Offer expenses amounted to ₹0.41 crore during the quarter, with a total of ₹46.60 crore utilized for this purpose. The total amount utilized across all objectives as of the end of the quarter stands at ₹573.40 crore, out of the total IPO size of ₹620.00 crore.

Key Observations

The report indicates that there have been no material deviations in the utilization of funds compared to the offer document. Shareholder approval was not required as there were no significant deviations. The company has also reported no deviation in the means of finance for the disclosed objects, and this marks the first monitoring agency report following the IPO.

As of September 30, 2026, the unutilized proceeds amounted to ₹46.60 crore. A portion of these unutilized funds, specifically ₹62.51 crore (including ₹15.91 crore for pending reimbursements), was held in the HDFC Bank – Public Offer Account.

Board and Audit Committee Approval

The draft Monitoring Agency Report was reviewed and approved by the Audit Committee of Augmont Enterprises Limited, and subsequently taken on record by the Board of Directors at their meetings held on November 4, 2026. This submission ensures compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Source: BSE

Previous Article

Godrej Agrovet reports 17% revenue growth and 22% PAT increase in Q2 FY27

Next Article

Sharda Cropchem reports 13% revenue growth in Q2 FY27